BIOTELEMETRY, INC. (BEAT) [Rocket]

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Healthcare	372.0	338.8	234.4	165.7	146.0	133.2	100.4
Research	54.5	50.6	38.8	32.6	21.9	19.7	20.3
Corporate and Other	12.6	10.1	13.6	10.1
Patient Services								93.6
Other					10.7	13.7	8.8	17.9
Total revenues [+]	439.1	399.5	286.8	208.3	178.5	166.6	129.5	111.5
Products								9.5
Services					21.9	19.7	20.3	8.3
Technology services					10.7	13.7	8.8
Healthcare					146.0	133.2	100.4	93.6
Revenue growth [+]	9.9%	39.3%	37.7%	16.7%	7.2%	28.6%	16.2%	-6.3%
Healthcare	9.8%	44.6%	41.5%	13.5%	9.6%	32.7%
Research	7.7%	30.3%	19.1%	49.0%	10.7%	-2.9%
Corporate and Other	25.2%	-25.7%	34.6%
Patient Services								-12.4%
Research Services							144.0%	672.3%
Cost of goods sold [+]	164.8	149.0	114.4	78.9	72.0	73.1	50.4	45.6
Cost of product sales								5.1
Cost of services					12.7	10.6	11.3	3.7
Cost of technology services					7.5	7.5	4.9
Gross profit	274.3	250.5	172.4	129.5	106.6	93.5	79.1	65.9
Gross margin	62.5%	62.7%	60.1%	62.1%	59.7%	56.1%	61.1%	59.1%
Selling, general and administrative [+]	170.8	152.6	118.3	84.5	75.8	73.9	62.8	58.2
Sales and marketing	50.7	42.8	35.3	28.6	27.9	28.8	26.3	25.6
General and administrative	120.1	109.7	83.0	55.9	47.9	45.1	36.6	32.6
Research and development	14.0	11.2	11.1	8.4	7.1	7.4	7.3	4.7
Equity in earnings	-1.3	-0.2	-0.4	-0.3
Other operating expenses	36.8	36.9	43.4	18.6	8.3	11.8	9.7	14.4
EBITDA [+]	94.4	89.7	27.7	32.0	27.8	12.9	11.5	-2.0
EBITDA growth	5.2%	223.4%	-13.3%	15.2%	114.8%	12.3%	-675.6%	462.1%
EBITDA margin	21.5%	22.5%	9.7%	15.4%	15.6%	7.8%	8.9%	-1.8%
Depreciation	43.0	40.2	28.6	10.5	9.0	8.9	10.0	8.0
EBITA	51.5	49.6	-0.8	21.4	18.8	4.1	1.5	-10.0
EBITA margin	11.7%	12.4%	-0.3%	10.3%	10.5%	2.4%	1.2%	-9.0%
Amortization of intangibles				3.7	3.5	3.7	2.3	1.3
EBIT [+]	51.5	49.6	-0.8	17.7	15.3	0.4	-0.8	-11.4
EBIT growth	3.8%	-6189.4%	-104.6%	16.0%	3942.9%	-147.2%	-93.0%	-8.9%
EBIT margin	11.7%	12.4%	-0.3%	8.5%	8.6%	0.2%	-0.6%	-10.2%
Non-recurring items			1.3		5.8	4.7	6.1	1.8
Interest expense	9.5	9.4	4.9	1.8	1.5
Interest expense	9.5	9.4	4.9	1.8	1.5
Other income (expense), net [+]	-2.2	1.4	-3.4	-0.1	-0.1	-7.8	-0.2	0.1
Gain (loss) on debt retirement			-0.5
Other	-13.0	-8.3	-8.6	-2.2	0.1	-7.8	-0.2	0.1
Pre-tax income	39.7	41.5	-10.4	15.8	7.9	-12.1	-7.1	-13.1
Income taxes	9.9	-0.4	6.7	-37.7	0.5	-2.3	0.2	-0.9
Tax rate	24.9%				5.9%	19.1%		6.9%
Minority interest		-0.9	-1.2
Net income	29.8	42.8	-16.0	53.4	7.4	-9.8	-7.3	-12.2
Net margin	6.8%	10.7%	-5.6%	25.6%	4.2%	-5.9%	-5.7%	-10.9%

Basic EPS [+]	$0.88	$1.31	($0.53)	$1.91	$0.27	($0.37)	($0.29)	($0.49)
Growth	-32.8%	-349.3%	-127.4%	598.7%	-174.0%	29.2%	-41.5%	-80.5%
Diluted EPS [+]	$0.82	$1.20	($0.53)	$1.75	$0.26	($0.37)	($0.29)	($0.49)
Growth	-31.6%	-327.9%	-130.0%	586.4%	-169.0%	29.2%	-41.5%	-80.5%

Shares outstanding (basic) [+]	33.9	32.7	30.4	27.9	27.1	26.4	25.5	24.9
Growth	3.8%	7.6%	8.8%	3.0%	2.5%	3.5%	2.4%	2.1%
Shares outstanding (diluted) [+]	36.4	35.8	30.4	30.5	29.1	26.4	25.5	24.9
Growth	1.8%	17.8%	-0.3%	4.8%	10.0%	3.5%	2.4%	2.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.